Services NST provided to Astex Pharmaceuticals included medical writing for:
"The NST teams we worked with delivered high-quality work, including clinical protocols, clinical study report and narrative writing along with performing Quality Reviews of our documents, allowing us to overcome our regulatory hurdles without losing pace on other projects. Importantly, their unique approach to preparing these documents generated outstanding products with only reasonable input from us and minimal revisions – a welcome contrast to other similar firms we had worked with in the past."
An important part of Astex’s portfolio is the development of hypomethylating agents for treatment of various diseases, including myelodysplastic syndromes and acute myeloid leukemia. NST was a drug development partner on Astex’s business-critical regulatory writing projects. Projects included clinical protocols, protocol amendments, clinical study reports and safety narratives. The NST team generated high-quality deliverables, largely autonomously, while simplifying complex concepts, drawing on their vast regulatory expertise. NST’s involvement provided valuable writing capacity when Astex’s in-house teams were fully occupied, enabling greater operational efficiency. NST endeavours made an invaluable contribution to Astex’s clinical pipeline.
Adaptimmune specialises in developing novel therapies for the treatment of resistant tumour types.
read moreA specialist pharmaceutical company dedicated to HIV medicines and research with an extensive portfolio of prescription.
read moreCleothena Enterprises Pty Ltd. is a forward-thinking biotechnology company focused on advancing innovative therapeutic.
read moreSynairgen is a UK-based biopharmaceutical company focused on developing innovative treatments for respiratory diseases,.
read moreRecardio is a life science company that focuses on drug-based regenerative therapeutic modalities for treatments of.
read moreThe British Society for Haematology (BSH), the UK’s largest haematology organisation, promotes excellence within the.
read moreThe FRAILOMIC initiative was an international research project aimed at improving the understanding, diagnosis, and.
read moreNabriva Therapeutics was incorporated as a spin-off from Sandoz GmbH Antibiotics Research Institute (ABRI) in Vienna..
read moreAssign’s business model relied on bespoke service providers like NST to deliver essential aspects of their business.
read moreBioKinetic Europe was a fully integrated clinical research organisation with its own purpose-designed clinical.
read moreGet our latest news and publications
Sign up to our news letterResources
Social
Contact us
Address
Niche Science & Technology
Unit 26 Falstaff House
Bardolph Road
Richmond TW9 2LH
United Kingdom
